BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 3234485)

  • 1. Inhibition of small intestine motility by cromakalim (BRL 34915).
    Buchheit KH; Bertholet A
    Eur J Pharmacol; 1988 Sep; 154(3):335-7. PubMed ID: 3234485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cromakalim on acetylcholine release and smooth muscle contraction in guinea-pig small intestine.
    Schwörer H; Kilbinger H
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):706-8. PubMed ID: 2770892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea-pig isolated renal pelvis and ureter.
    Maggi CA; Giuliani S; Santicioli P
    Br J Pharmacol; 1994 Mar; 111(3):687-94. PubMed ID: 8019747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists.
    McPherson GA; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):201-6. PubMed ID: 2116201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of sulfonylurea receptors and the action of potassium channel openers on cholinergic neurotransmission in guinea pig isolated small intestine.
    Zini S; Ben-Ari Y; Ashford ML
    J Pharmacol Exp Ther; 1991 Nov; 259(2):566-73. PubMed ID: 1658303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of K+ channel blockers and cromakalim (BRL 34915) on the mechanical activity of guinea pig detrusor smooth muscle.
    Grant TL; Zuzack JS
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1158-64. PubMed ID: 1722252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the potassium channel activator cromakalim (BRL 34915) as a bronchodilator in the guinea-pig: comparison with nifedipine.
    Arch JR; Buckle DR; Bumstead J; Clarke GD; Taylor JF; Taylor SG
    Br J Pharmacol; 1988 Nov; 95(3):763-70. PubMed ID: 3207991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the potassium channel activator BRL 38227 as an inhaled bronchodilator in the guinea-pig: contrast with nifedipine and salbutamol.
    Bowring NE; Buckle DR; Clarke GD; Taylor JF; Arch JR
    Pulm Pharmacol; 1991; 4(2):99-105. PubMed ID: 1804502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cromakalim (BRL 34915) on potassium conductances in CA3 neurons of the guinea-pig hippocampus in vitro.
    Alzheimer C; Sutor B; ten Bruggencate G
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Oct; 340(4):465-71. PubMed ID: 2586636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K+ channel openers delay intestinal transit and have antidiarrheal activity.
    Poggioli R; Benelli A; Arletti R; Cavazzuti E; Bertolini A
    Eur J Pharmacol; 1995 Dec; 287(2):207-9. PubMed ID: 8749038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of cromakalim-induced relaxations in the smooth muscle cells of guinea-pig mesenteric artery and vein.
    Nakao K; Okabe K; Kitamura K; Kuriyama H; Weston AH
    Br J Pharmacol; 1988 Nov; 95(3):795-804. PubMed ID: 2974740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cromakalim (BRL 34915) acts on an inwardly rectifying neuronal K+ conductance, which is similar to that activated by adenosine.
    Alzheimer C; Sutor B; ten Bruggencate G
    Pflugers Arch; 1989; 414 Suppl 1():S121-2. PubMed ID: 2780226
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cromakalim on the membrane potassium permeability of frog skeletal muscle in vitro.
    Benton DC; Haylett DG
    Br J Pharmacol; 1992 Sep; 107(1):152-5. PubMed ID: 1422569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure.
    Ando T; Kume H; Urata Y; Takagi K
    Clin Exp Allergy; 1997 Jun; 27(6):705-13. PubMed ID: 9208193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of guinea-pig tracheal smooth muscle responsiveness by the potassium channel openers NIP-121 and cromakalim.
    Shikada K; Yamamoto A; Tanaka S
    Jpn J Pharmacol; 1992; 58 Suppl 2():334P. PubMed ID: 1507583
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the effects of RP 49356, cromakalim and nifedipine on guinea-pig trachea in vitro.
    Brown TJ; Sweetland J; Raeburn D
    Pflugers Arch; 1989; 414 Suppl 1():S188-9. PubMed ID: 2780257
    [No Abstract]   [Full Text] [Related]  

  • 18. Potassium channel blockers and the effects of cromakalim on the smooth muscle of the guinea-pig bladder.
    Fujii K; Foster CD; Brading AF; Parekh AB
    Br J Pharmacol; 1990 Apr; 99(4):779-85. PubMed ID: 2361173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine.
    Raeburn D; Brown TJ
    J Pharmacol Exp Ther; 1991 Feb; 256(2):480-5. PubMed ID: 1899701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channel openers, NIP-121 and cromakalim, enhance the relaxation induced by sodium nitroprusside in the guinea-pig isolated trachea.
    Shikada K; Tanaka S
    Br J Pharmacol; 1992 Dec; 107(4):1116-20. PubMed ID: 1334750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.